Product
  • Product
  • Supplier
  • Inquiry

    EN

    Home > API > Circulatory System Drugs (Find 568 items)

    Circulatory System Drugs

    Vildagliptin

    (274901-16-5)
    Vildagliptin (previously LAF237, trade names Galvus, Zomelis,) is an oral anti-hyperglycemic agent (anti-diabetic drug) of the new dipeptidyl peptidase-4 (DPP-4) inhibitor class of drugs. Vildagliptin inhibits the inactivation of GLP-1 and GIP by DPP-4, allowing GLP-1 and GIP to potentiate the secretion of insulin in the beta cells and suppress glucagon release by the alpha cells of the islets of Langerhans in the pancreas.Vildagliptin has been shown to reduce hyperglycemia in type 2 diabetes mellitus.

    Suppliers of Vildagliptin

    Request for quotation , get quotes from more suppliers.

    Oleuropein

    (32619-42-4)
    Oleuropein is a tyrosol ester derivative of elenolic acid and phenolic glycoside found in olive oil. Oleuropein shows antioxidant, anti-ischemic and hypolipidemic activity. Oleuropein has also been used as an immunomodulator .

    Suppliers of Oleuropein

    Request for quotation , get quotes from more suppliers.

    Telmisartan

    (144701-48-4)
    1. Cardiotonic
    2. Telmisartan is an angiotensin II receptor antagonist.
    3. Anti-cancer agent
    4. Used alone or in combination with other classes of antihypertensives for the treatment of hypertension. Also used in the treatment of diabetic nephropathy in hypertensive patients with type 2 diabetes mellitus, as well as the treatment of congestive heart

    Suppliers of Telmisartan

    Request for quotation , get quotes from more suppliers.

    Atorvastatin Calcium

    (134523-03-8)
    1. A selective, competitive HMG-CoA reductase inhibitor. The only drug in its class specfically indicated for lowering both elevated LDL-cholesterol and triglycerides in patients with hypercholesterolemia
    2. A selective, competitive HMG-CoA reductase inhibitor. Atorvastatin is the only drug in its class specfically indicated for lowering both elevated LDL-cholesterol and triglycerides in patients with hypercholesterolemia.
    3. Antihyperlipidemic, HMGCoA reductase inhibitor
    4. DMSO and EtOH soluble
    5. The primary uses of atorvastatin is for the treatment of dyslipidemia and the prevention of cardiovascular disease.

    Simvastatin

    (79902-63-9)
    anti-hyperlipoproteinemic, 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor

    Suppliers of Simvastatin

    Request for quotation , get quotes from more suppliers.

    3-Methyl-2-[pentanoyl-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]amino]-butanoic acid

    (137862-53-4)
    May be used as a first line agent to treat uncomplicated hypertension, isolated systolic hypertension and left ventricular hypertrophy. May be used as a first line agent to delay progression of diabetic nephropathy. Losartan may be also used as a second l

    Irbesartan

    (138402-11-6)
    For the treatment of hypertension, as well as diabetic nephropathy with an elevated serum creatinine and proteinuria (>300 mg/day) in patients with type 2 diabetes and hypertension. Irbesartan is also used as a second line agent in the treatment of conges

    Suppliers of Irbesartan

    Request for quotation , get quotes from more suppliers.

    Candesartan cilexetil

    (145040-37-5)
    Ester prodrug; hydrolized in vivo to the active carboxylic acid. Used in treatment of congestive heart failure. Antihypertensive

    Chondroitin Sulfate

    (9007-28-7)
    Chondroitin sulfate is described as a skin-conditioning agent, with possible anti-inflammatory properties. It can be found in such products as moisturizers and night skin care preparations. It is a derivative of natural mucopolysaccharides.
    Circulatory system drugs are about drugs that have the function of regulating the human circulatory system. The circulatory system is a system of body fluids (including blood, lymph and tissue fluids) and pipes through which circulation flows. Circulatory system drugs mainly include cardiovascular system drugs and diuretics. "Circulatory System Drugs" on Echemi covers lipid regulating drugs, angina pectoris drugs, calcium channel blockers, anti-congestive heart failure drugs, antihypertensive drugs, antiarrhythmics drugs, anti shock vasoactive drugs, ace inhibitor, peripheral vasodilators, heart failure treatments and drugs, Anti-atherosclerotic drugs, β-adrenergic receptor blockers and other circulatory system drugs, mainly supply raw materials for such drugs.
    Suggestions
    Email:
    Message:
    Send Message